Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes

Journal of Viral Hepatitis

Volumn 22, Issue 10, 2015, Pages 817-827

  Sarkar, N ^a   Panigrahi, R ^a,g   Pal, A ^a   Biswas, A ^a,h   Singh, S P ^b,c   Kar, S K ^b   Bandopadhyay, M ^a   Das, D ^a   Saha, D ^a   Kanda, T ^d   Sugiyama, M ^e   Chakrabarti, S ^a   Banerjee, A ^a,i   Chakravarty, Runu ^a,f  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b SCB MEDICAL COLLEGE   (India)

^c Kalinga Gastroenterology Foundation   (India)

^d CHIBA UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^g TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h SCRIPPS RESEARCH INSTITUTE   (United States)

ⁱ Translational Health Science and Technology Institute   (India)

Author keywords

C EBP ; chronic; hepatitis B virus; miRNA; Toll like receptors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENTARY DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; MICRORNA 155; TOLL LIKE RECEPTOR 7; VIRUS DNA; MICRORNA; MIRN155 MICRORNA, HUMAN;

ARTICLE; CELL VIABILITY; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SYNTHESIS; DOWN REGULATION; HEPATITIS B VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSCRIPTION; BIOSYNTHESIS; CELL LINE; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER; MICRORNAS; TOLL-LIKE RECEPTOR 7; VIRUS REPLICATION;

EID: 84941188057     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12390     Document Type: Article

References (44)

1. Ganem D, Prince AM,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
2. Visvanathan K, Lewin SR,. Immunopathogenesis: role of innate and adaptive immune responses. Semin Liver Dis 2006; 26: 104-115.
3. Rehermann B, Fowler P, Sidney J, et al,. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-1058.
4. Ait-Goughoulte M, Zoulim F, Durantel D,. Innate antiviral immune responses to hepatitis B virus. Viruses 2010; 2: 1394-1410.
5. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
6. Yu S, Chen J, Wu M, et al,. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 2010; 91: 2080-2090.
7. Wu J, Meng Z, Jiang M, et al,. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009; 49: 1132-1140.
8. Wu J, Lu M, Meng Z, et al,. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007; 46: 1769-1778.
9. Wu JF, Chen CH, Ni YH, et al,. Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan. J Infect Dis 2012; 206: 662-668.
10. Xia C, Lu M, Zhang Z, Meng Z, Zhang Z, Shi C,. TLRs antiviral effect on hepatitis B virus in HepG2 cells. J Appl Microbiol 2008; 105: 1720-1727.
11. O'Neill LA, Sheedy FJ, McCoy CE,. MicroRNAs: the fine-tuners of Toll-like receptor signaling. Nat Rev Immunol 2011; 11: 163-175.
12. Kim VN, Nam JW,. Genomics of microRNA. Trends Genet 2006; 22: 165-173.
13. Su C, Hou Z, Zhang C, Tian Z, Zhang J,. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011; 8: 354.
14. Damania P, Sen B, Dar SB, et al,. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One 2014; 9: 45-48.
15. Huang J, Ma G, Fu L, et al,. Pseudorabies viral replication is inhibited by a novel target of miR-21. Virology 2014; 456-457: 319-328.
16. Otsuka M, Jing Q, Georgel P, et al,. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR-24 and miR-93 expression. Immunity 2007; 27: 123-134.
17. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005; 309: 1577-1581.
18. Qiu X, Dong S, Qiao F, et al,. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32: 3296-3305.
19. Rodriguez A, Vigorito E, Clare S, et al,. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608-611.
20. Zhou H, Huang X, Cui H, et al,. miR-155 and its star-form partner miR-155∗ cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010; 116: 5885-5894.
21. Dudda JC, Salaun B, Ji Y, et al,. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 2013; 38: 742-753.
22. Swaminathan G, Rossi F, Sierra LJ, et al,. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012; 8: e1002937.
23. Lok AS, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
24. Martinez-Nunez RT, Louafi F, Friedmann PS, Sanchez-Elsner T,. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 2009; 284: 16334-16342.
25. Chen Z, Cheng Y, Xu Y, et al,. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol 2008; 128: 400-408.
26. Ji F, Yang B, Peng X, et al,. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011; 18: e242-e251.
27. Xiong Y, Chen S, Liu L, Zhao Y, Lin W, Nie J,. Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine. Clin Vaccine Immunol 2013; 20: 1089-1091.
28. Chandra PK, Banerjee A, Datta S, Chakravarty R,. G1862T mutation among hepatitis B virus-infected individuals: association with viral genotypes and disease outcome in Kolkata, Eastern India. Intervirology 2007; 50: 173-180.
29. Wu S, Kanda T, Imazeki F, et al,. Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines. Cancer Lett 2011; 312: 33-42.
30. Zhang X, Ma Z, Liu H, et al,. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. J Hepatol 2012; 57: 522-528.
31. Lanford RE, Guerra B, Chavez D, et al,. GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. J Gastroenterol 2013; 144: 1508-1517.
32. Visvanathan K, Skinner NA, Thompson AJ, et al,. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102-110.
33. Fu L, Cheng YC,. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus. Antimicrob Agents Chemother 2000; 44: 3402-3407.
34. Han Q, Lan P, Zhang J, Zhang C, Tian Z,. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation. J Gastroenterol Hepatol 2013; 28: 132-137.
35. Xu N, Yao HP, Sun Z, Chen Z,. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol Sin 2008; 29: 239-244.
36. Lindsay MA,. microRNAs and the immune response. Trends Immunol 2008; 29: 343-351.
37. Liu D, Wu A, Cui L, et al,. Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90β. PLoS One 2014; 9: e91658.
38. Sells MA, Zelent AZ, Shvartsman M, Acs G,. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 1988; 62: 2836-2844.
39. Liu WH, Yeh SH, Chen PJ,. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta 2011; 1809: 678-685.
40. Lopez-Cabrera M, Letovsky J, Hu KQ, Siddiqui A,. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 1991; 183: 825-829.
41. Bock CT, Kubicka S, Manns MP, Trautwein C,. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor. Hepatology 1999; 29: 1236-1247.
42. Lopez-Cabrera M, Letovsky J, Hu KQ, Siddiqui A,. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc Natl Acad Sci USA 1990; 87: 5069-5073.
43. Seeger C, Mason WS,. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
44. Janssen HL, Reesink HW, Lawitz EJ, et al,. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-1694.